Home Wealth  Money Cell Therapeutics Says Panel Confirms Study Robustness

Cell Therapeutics Says Panel Confirms Study Robustness

Posted: Sep. 29th, 2011  |  By Forbes

powered by Forbes

RSS Syndicated News Email a Friend Suggest an Article Share Visit Website

Cell Therapeutics shares are getting a boost today after the company announced that a second independent radiology assessment of data from a clinical trial of the companys antitumor treatment pixantrone confirmed the statistical robustness of the data.

The response and progression endpoint data was previously submitted to the US Food and Drug Administration with the new drug application for pixantrone.

The second assessment was recommended by the FDAs Office of New Drugs as part of Cell Therapeutics (nasdaq: CTIC - news - people ) appeal to the complete response letter it had previously received from the FDA.

The company said it plans on resubmitting the drug as early as next month for accelerated approval, which could provide an FDA action date by April 2012.

Cell Therapeutics had announced earlier in the week that a UnitedHealth Group (nyse: UNH - news - people ) executive, Reed Tuckson, has joined its board.

This year, the company has licensed rights from Chroma Therapeutics to develop tosedostat, and it has an ongoing relationship with Novartis (nyse: NVS - news - people ) for the licensing of Opaxio.

Market News Video produces and distributes online videos about stocks and investing.




Share on Facebook Share
See Next Article
Need to Get Away?
Top 10 Business Hotels
Who says you can’t mix business with pleasure?
Read More
More Articles from Forbes.com

advertisement
Quick Links
Autos
Boating
Real Estate
Luxury Travel
Fashion
Search Real Estate
Find Your Dream Home
Search for homes by
State, Country or Style.
Event Calendar
advertisement
Current News & Features
The Montblanc Meisterstück Is On Point
The Winning Wines of the 2015 En Primeur Campaign
Say Hello To The iPad Pro
Farm-To-Bottle: The Importance of Going Organic With Your Spirits
An Evening at One Of The Most Prestigious Private Dining Clubs In The World
Get The 411 On The Porsche 911 R
The Maserati Multi70 Trimaran Takes To The Seas
The New Aston Martin DB11 Takes On Heat
Louis Vuitton Rolls Out Their New Luggage Line
Can China be a Driving Force in the Superyacht Industry?
See the complete list
 
Featured Photo Gallery
See the complete list
THINGS WE LIKE